Falco, Antonia
Basile, Anna
Raimondo, Annunziata
Guglielmi, Giulia
Rosati, Alessandra
De Marco, Margot
Turco, Maria Caterina
Pascale, Maria
Lembo, Serena
Funding for this research was provided by:
UniversitĂ degli Studi di Salerno (FARB)
Article History
Received: 1 May 2024
Accepted: 3 May 2024
First Online: 15 May 2024
Declarations
:
: IRB approved with N° 0037908 (date: February 18th, 2021) by Campania Sud Ethics Committee.
: not applicable.
: AR, MDM and MCT are shareholders of the academic spin-off FIBROSYS developing diagnostic and therapeutic tools based on BAG3 protein and its receptor. The remaining authors have no conflict of interest to disclose.